AbstrAct: This paper focuses on the problem of partially matched samples in the presence of confounders. We propose using propensity score matching to adjust for confounding factors for the subset of data with incomplete pairs, followed by integrating the P-values computed from the complete and incomplete paired samples, respectively. Several simulations and a case study on DNA methylation are considered to evaluate the operating characteristics of the proposed method.
Introduction
The advancement in biotechnologies has revolutionized numerous disciplines including biology and medicine. Several high-throughput platforms including whole genome arrays and the next-generation sequencing instruments are available for profiling large-scale omics data. These cutting edge biotechnologies have spurred rapid biomarker discovery and personalized medicine approach in multiple diseases, in particular, cancer research. In recent years, genomewide profiling utilizing these technologies has been carried out to identify biomarkers associated with cancer development and progression. In this paper, we consider the matched pairs samples for identifying differentially expressed biomarkers between two groups. Matched/paired study design is commonly used in omics/biomarkers profiling because it automatically accounts for confounding factors. Examples of matched/paired designs include profiling n (1) tumor and adjacent normal lesions, (2) pre-and post-drug treatment samples, or (3) one-to-one matching of patients by demographic covariates (eg, age, gender, race, etc.) from the two groups of interest. We will use the tumor versus normal samples hereafter for expository purpose.
Ideally, one expects a total of 2n samples from such matched/paired design. However, in practice, circumstances such as RNA degradation, array failure, or insufficient resources could result in a subset of patients missing in either the tumor or matched normal biomarker profiles. For example, n 1 (,n) patients have both the tumor and matched normal profiles, whereas n 2 and n 3 patients have only tumor and normal samples, respectively. Such incomplete or missing paired samples are also known as partially matched samples.
Several methods have been developed to analyze partially matched data generated from the Gaussian distribution. [1] [2] [3] [4] Recently, Kuan and Huang 5 and Yu et al. 6 extended the approach to non-parametric setting, which does not require the Gaussian assumption. Specifically in Kuan and Huang, 5 we introduced a simple and robust method for analyzing partially matched samples based on the weighted Z-test to combine the P-values computed using (1) paired sample tests (eg, paired t-test or Wilcoxon sign rank test) on the n 1 matched pairs and (2) two-sample tests (eg, two-sample t-test or Mann-Whitney test) on the incomplete n 2 and n 3 pairs. The P-value pooling approach has been shown to achieve good operating characteristics compared to existing methods.
As alluded earlier, matched/paired design is an appealing approach to avoid confounding. However, when a subset of samples has incomplete pairs in partially matched samples scenarios, this can result in unbalanced covariates between the tumor and normal groups. Nonetheless, the above-mentioned methods assume that the confounding factors among the n 2 and n 3 incomplete matched pairs are absent or negligible. If this assumption does not hold, the conclusions drawn from these methods are no longer valid. In this paper, we introduce an approach to adjust for potential confounders based on propensity score matching method in partially matched samples. Our paper is organized into five sections. In Section 2, we describe the proposed method, followed by Sections 3 and 4, which demonstrate the operating characteristics of the proposed approach in simulations and case study, respectively. We conclude with a discussion in Section 5.
Method
Let (X i , Y i ) be a matched pair for subject i, i = 1, …, n, where X i and Y i are the tumor and normal measurements, respectively. Without loss of generality, we assume that (X i , Y i ) are complete matched pairs for i = 1, …, n 1 ; Y i 's are missing for i = n 1 + 1, … , n 1 + n 2 , and X i 's are missing for i = n 1 + n 2 + 1, …, n 1 + n 2 + n 3 . That is, n 1 patients have both the tumor and matched normal profiles, whereas n 2 and n 3 patients have only tumor or normal samples, respectively. Let Z i = (Z 1i , …, Z pi ) denote the p covariates for subject i, for instance, Z 1i = age, Z 2i = gender, etc. The first step is to create pseudo-pairs between the n 2 and n 3 incomplete pairs by matching the covariate information. We will use propensity score method to accomplish this step. To simplify the notation, we introduce subscript j to denote sample j, j = 1, …, n 2 + n 3 among the incomplete pairs, and let Z j denote the corresponding covariate information. Let O j denote the measurement for subject j. Note that O j = X j for j = 1, …, n 2 and O j = Y j for j = n 2 + 1, …, n 2 + n 3 . We also let G j denote the group indicator for sample j, ie, G j = 1 and 2 for normal and tumor samples, respectively.
Propensity score method. The propensity score method, introduced by Rosenbaum and Rubin, 7 is a popular approach in observational studies to create balance in multiple confounding covariates between the two groups. The propensity score is defined as
There are several approaches for estimating e j , including logistic regression and machine learning techniques such as boosted regression, 8 classification trees (CART), and random forests. A comparison of these methods is provided in Lee et al. 9 There are four main methods for removing confounding effects based on e j , namely (1) propensity score matching, (2) stratification on propensity score, (3) covariate adjustment using propensity score, and (4) inverse probability weighting by propensity score. We refer the readers to Austin 10 for a review on these different approaches. In this paper, we consider two approaches based on propensity scores to account for confounding effects. The first approach is covariate adjustment using propensity score via a linear model
where ε j ∼ N(0, 1) if the biomarker measurements are approximately Gaussian distributed after appropriate normalization and transformation. Otherwise, one can use the generalized linear model 11 with appropriate link function for non-Gaussian data. One can then evaluate if the expression of tumor is significantly different from normal by testing the hypothesis H 0 : β
The second approach is based on Mahalanobis distance on covariate ranks with propensity score caliper 12 for matching the covariates between the n 2 tumor and n 3 normal samples from incomplete pairs. Let r j be the vectors of covariate ranks for sample j. The Mahalanobis distance between sample j in the tumor group and sample k in the normal group is defined as
where  Σ is the estimated pooled covariance matrix for the ranks. On the other hand, the propensity score caliper c is defined as the maximum propensity score distance between sample j and k allowed within a match. In other words,
The choice of caliper width is related to bias-variance trade-off where small caliper width results in bias reduction but at the expense of increasing variance, and vice versa. 13 A few studies have been conducted to investigate the optimal caliper width in propensity score matching, including the work of Austin 13 and Wang et al. 14 Based on these works and our own experience in propensity score matching, we recommend using caliper width equal to 0.2 of the standard deviation of the logit of the propensity score, which tends to have better performance, ie, ( ) 
where α is the overall within-pair mean difference between tumor and normal samples, . On the other hand, the generalized non-parametric test for one-to-many pairing can be carried out via the aligned rank test of Hodges and Lehmann 20 if the data are nonGaussian. We refer the readers to Hodges and Lehmann, 20 and Heller et al. 21 for additional details on implementing the aligned rank test.
P-values pooling. We follow the idea of our earlier work in Kuan and Huang 5 to test if the biomarker is significantly up or down regulated in tumor compared to normal samples by pooling the P-values from the n 1 complete and (n 2 , n 3 ) incomplete pairs. The P-value for the n 1 complete matched pairs is computed using either the paired sample t-test or Wilcoxon signed-rank test, denoted as p 1 . On the other hand, the P-value for the incomplete pairs p 2 is computed based on the linear model using propensity score as covariate (equation (1) of Section 2.1), the generalized t-test, or aligned signed rank test (Section 2.2). The next step is to pool the two P-values by borrowing the idea of meta-analysis. Several methods are available for pooling P-values including the inverse normal and Fisher's methods. In Kuan and Huang, 5 we showed that pooling P-values based on weighted Z-test has good operating characteristics compared to other methods. The weighted Z-test for combining the P-values is based on transforming the P-values into Z-score Z a = Φ −1
(1 -p k ), k = 1, 2. The combined P-value by the weighted Z-test 5, 22 is given by
where w k 's are the corresponding weights. Although different choices of weights have been proposed in the literature, Kuan and Huang, 5 Zaykin 23 showed that setting the weights as the square root of the sample sizes works well in practice. Thus, we set 1 1 2 w n = and 2 2 3 w n n = + . In addition, pooling P-values is only meaningful if p 1 and p 2 are computed from one-sided hypothesis tests to avoid directional conflict. One can obtain a two-sided combined P-value as follows. Let p 1 and p 2 be the one-sided P-value for the same alternative (eg, "greater") hypothesis, and p c be the combined one-sided P-value from equation (2) . The two-sided P-value is given by 
simulation
We carry out simulation to evaluate the performance of propensity score method to adjust for potential confounders in partially matched samples. n paired sample measurements (X ij , Y ij ) of a biomarker i for the tumor and matched normal group are generated from bivariate Gaussian distribution,
where Z 1 and Z 2 are confounders, and µ X and µ Y are the true mean expressions for tumor and normal groups, respectively. We consider (n 1 , n 2 , n 3 ) = (70, 15, 15), (50, 25, 25) , and (30, 35, 35) and set σ X = σ Y = 1, whereas ρ ∼ U(0, 1) to capture various degrees of correlation between tumor and normal matched pairs. In addition, we set µ Y = 0 and µ X = 0, 0.1, 0.2, …, 0.5 for different effect sizes, and β = 0, 0.5, 1, and 2 for zero, moderate, strong, and very strong confounding effects.
To simulate unbalanced confounders arising from incomplete matched pairs, we generate
and
We compare the performance of the following methods in our simulation studies: a. Gold standard (Gold-std): The P-value was computed from paired sample t-test on n 1 + n 2 + n 3 original matched pairs assuming complete data set. This is the reference test. b. Paired only: The P-value was computed from paired sample t-test on the n 1 complete matched pairs only, and discarding the n 2 and n 3 incomplete pairs. c. Two sample: Combining the P-value from paired sample t-test on the complete n 1 matched pairs and the P-value from two-sample t-test on the incomplete n 2 and n 3 samples using the weighted Z-test approach. d. Propensity score with full matching (FM-PS): Combining the P-value from paired sample t-test on the complete n 1 matched pairs and the P-value from generalized t-test on full matched data by Mahalanobis distance with propensity score caliper c = 0.2 on the incomplete n 2 and n 3 samples. e. Propensity score with regression adjustment (Reg-PS):
Combining the P-value from paired sample t-test on the complete n 1 matched pairs and the P-value from linear regression model using propensity score as covariate on the incomplete n 2 and n 3 samples.
single biomarker. We first evaluate the performance of propensity score methods in adjusting for unbalanced covariates in single biomarker setting. Table 1 reports the average empirical Type I error at nominal α = 0.05 over 10,000 replications. When there is no confounding effect, ie, β = 0, all the methods control the Type I error. However, for β ≠ 0, the two-sample method exhibits the largest Type I error inflation. On the other hand, paired only, FM-PS, and Reg-PS methods control the Type I error under all the scenarios considered in the simulation. Figure 1 shows the average power for different combinations of n 1 , n 2 , n 3 , and β for methods that control the Type I error (empirical Type I error # 0.055). As expected, missing samples in incomplete matched pairs reduce the power compared to complete data set (Gold-std). However, incorporating the incomplete matched pairs with proper adjustment for confounders via FM-PS or Reg-PS methods exhibit increased statistical power compared to using only the n 1 paired samples when n 2 and n 3 are substantially large. When n 2 and n 3 are small relative to n 1 , using only the n 1 paired samples is comparable to methods that incorporate n 2 and n 3 . Both FM-PS and Reg-PS methods show comparable performance in this simulation study.
Multiple biomarkers. As omics data involve testing multiple biomarkers simultaneously (within a multiple hypothesis testing framework), we also simulate the observations from multiple biomarkers setting. We consider 1000 biomarkers and repeat each simulation setting over 100 repli cations. We use the false discovery rate (FDR) procedure of Benjamini and Hochberg 24 to adjust for multiple hypothesis testing. Figure 2 reports the average empirical FDR for the different methods at nominal FDR = 0.05. Similar to the single biomarker case, two-sample method exhibits the largest inflated empirical FDR for β ≠ 0. On the other hand, FM-PS, Reg-PS, and paired only methods control the FDR across the different scenarios. Figure 3 shows 
case study
We illustrate the proposed propensity score adjustment for partially matched samples on a publicly available DNA methylation data from Selamat et al. 25 (downloaded from Gene Expression Omnibus (GEO) under accession number GSE32861). The data set consists of 58 matched pairs of lung adenocarcinoma and adjacent non-tumor lung tissue after removing paired sample 3023_T/N. 25 Methylation for these samples was profiled using the Illumina HumanMethylation27 BeadChip, which covers 27,578 CpGs. We use a subset of baseline covariates measured for each sample (ie, age, smoking status, stage, recurrence, KRAS mutation, EGFR mutation, and LKB1 mutation) to illustrate the performance of the different methods. Age and stage are continuous and ordinal variables, respectively, whereas the other covariates are binary variables.
We randomly choose n 1 out of 58 matched pairs to be complete matched pairs. Next, we generate 58 − n 1 indicator variables, ie, δ k , k = 1, …, 58 − n 1 , where
after standardizing each covariate. This function generates approximately equal number of 0s and 1s on average. Among the remaining 58 -n 1 pairs, we set n 2 pairs to be missing in non-tumor lung tissue corresponding to those with δ k = 1, and the remaining to be missing in lung adenocarcinoma. We consider n 1 = 10, 20, 30, 40, and for each n 1 , the process is repeated 50 times. µ T n 1 =70 n 2 =15 n 3 =15 beta=0 n 1 =70 n 2 =15 n 3 =15 beta=0.5 n 1 =70 n 2 =15 n 3 =15 beta=1 n 1 =70 n 2 =15 n 3 =15 beta=2 n 1 =50 n 2 =25 n 3 =25 beta=0 n 1 =50 n 2 =25 n 3 =25 beta=0.5 n 1 =50 n 2 =25 n 3 =25 beta=1 n 1 =50 n 2 =25 n 3 =25 beta=2 n 1 =30 n 2 =35 n 3 =35 beta=0 n 1 =30 n 2 =35 n 3 =35 beta=0.5 n 1 =30 n 2 =35 n 3 =35 beta=1 n 1 =30 n 2 =35 n 3 =35 beta=2 figure 1. average power at nominal α = 0.05. sample size (n 1 , n 2 , n 3 ) and effect of confounding β are indicated in the header of each plot. Power curves for methods that did not control type I error (ie, empirical type I error . 0.055) are not shown.
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We apply FM-PS, Reg-PS, two-sample, and paired only methods on the logit-transformed methylation β-values, ie, log(β/ (1 − β) ) 26, 27 of each CpG. Since CpGs that are truly differentially methylated between lung adenocarcinoma and nontumor lung tissues are unknown in the case study, we use the results from paired sample t-test on the full 58 matched pairs as Gold-std. We define the true positive CpGs as the subset of CpGs that are significant at the Benjamini and Hochberg 24 FDR of 0.05 for the Gold-std method. We compare the list of significant CpGs identified by FM-PS, Reg-PS, two-sample, and paired only methods at FDR = 0.05 to the true positive CpGs. In Table 2 , we report the average empirical FDR, FNR, and average true positive (ATP) CpGs identified by each method. The ATP CpG is also the number of overlapping CpGs identified by each method and the Gold-std method. Two-sample method declares a larger number of false positives as indicated by the inflated empirical FDR. In this case study, the effect of confounding is moderate; thus, FM-PS, Reg-PS, and paired only methods are able to control the FDR. However, both FM-PS and Reg-PS methods have lower FNR and larger ATP compared to paired only method. This shows that the propensity score method for partially matched samples is able to adjust for confounders and improve the power of detecting differentially methylated CpGs.
We carry out a gene ontology (GO) analysis to provide biological insights into the list of significant CpGs at FDR = 0.05 identified from the Gold-std method using the Bioconductor package topGO. 28 We consider both the elim Fisher's exact test (elim.Fisher) and elim Kolmogorov-Smirnov test (elim.KS) implemented in topGO based on Alexa et al. 29 The elim method has been shown to improve interpretation of the GO analysis by integrating GO graph topology and iteratively removing genes that map to significant GO terms from a higher level GO terms. 29 The P-values from each of the test are adjusted via the Benjamini-Hochberg method.
24 Tables 3-5 report the GO terms corresponding to biological process (BP), molecular function (MF), and cellular component (CC) that exhibit adjusted P-values ,0.05 by both the elim.Fisher and elim.KS test, respectively. For example, the BP GO analysis identifies a GO term related to positive regulation of ERK1 and ERK2 cascade, which has been shown to be implicated in lung adenocarcinomas. 
average empirical fDr at nominal fDr = 0.05. sample size (n 1 , n 2 , n 3 ) and effect of confounding β are indicated in the header of each plot.
Notes: ○: Gold-std, ∆: fm-Ps, +: reg-Ps, × : two-sample, and ◊: paired only.
discussion
Partially matched samples could give rise to unbalanced covariate distribution among the incomplete matched pairs in large-scale matched pair omics studies. This paper extends the P-value pooling method of Kuan and Huang 5 to a framework based on propensity score for adjusting unbalanced covariate distribution among the incomplete matched pairs. We consider two approaches using propensity score, namely, (1) full matching followed by generalized t-test (FM-PS) and (2) propensity score as covariate in regression model (Reg-PS). Both methods are able to reduce the number of false positives by accounting for the confounders. Currently, we use the full matching approach based on Mahalanobis distance with propensity score calipers [15] [16] [17] and the one-way random effects ANOVA model 19 for deriving the generalized paired t-test. One can also use other matching algorithms based on propensity score. 10 In this paper, we assume that the biomarker measurements are properly transformed such that they are approximately Gaussian distributed. If Gaussian assumption is violated, one can replace the generalized paired t-test with the generalized non-parametric aligned rank test of Hodges and Lehmann 20 and Heller et al. 21 in FM-PS method, and replace regular linear regression with generalized linear models. 11 For instance, in our case study on DNA methylation, the analysis is carried out on the logit transformed beta values (also known as M values). An alternative approach is to analyze the untransformed beta values using beta regression in the Reg-PS method. The choice of analyzing DNA methylation data on either beta values or M values is an ongoing active research. 32, 33 Both the FM-PS and Reg-PS methods exhibit comparable performance in both our simulations and case study. In this paper, we assume a linear propensity score-outcome relationship that enables us to apply direct adjustment with a linear propensity score term in Reg-PS. In such cases, Reg-PS method is computationally more efficient and easier to implement compared to FM-PS method. However, if the propensity score-outcome relationship is non-linear, one will need to consider more complicated models, for instance, the generalized additive model (GAM) as proposed in Myers and Louis. 34 In such cases, the FM-PS method may be a better alternative as this approach does not require specification of the propensity score-outcome relationship. Thus, we recommend that the users compare the results from both Reg-PS and FM-PS methods in practice.
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